The Effects of Omega-3 plus Vitamin E on Metabolic Syndrome Indicators And insulin resistance in Overweight Women with Polycystic Ovary Syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200812048379N1

Enrollment

Registered

2020-10-26

Start date

2018-04-21

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome.

Interventions

Intervention 1: Intervention group: every day 2 capsul 1000mg Omega 3 and one 400 IU vitamin E of DANA factory for 60 days. Intervention 2: Control group:every day 2 plasebo of omega 3 and one plaseb

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: oligo-ovulation or anovulation the manifestation of hyper-androgenemia or symptom of hyperandrogenism the viewing of polycystic ovaries in ultrasound

Exclusion criteria

Exclusion criteria: cardiovascullar deases kidney diseases diabetes Cushing's syndrome were hepatitis non-alcoholic fatty liver thyroid disorders

Design outcomes

Primary

Measure	Time frame
FBS. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: 10cc of venous blood was collected before and after the trial and after measuring with special kits.;Triglyceride. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: 10cc of venous blood was collected before and after the trial and after measuring with special kits.;Low density lipoproteien. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: 10cc of venous blood was collected before and after the trial and after measuring with special kits.;Fasting insulin. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: 10cc of venous blood was collected before and after the trial and after measuring with special kits.;Ligh density lipoproteien. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: 10cc of venous blood was collected before and after the trial and after measuring with special kits.;Waist cicumfrance. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: was measured in standing position from the lowest rib to the extremity of the pelvic bone fracture using an anthropometric meter.;Systolic blood pressure. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: after 5 minut of rest with mercury barometer.;Diastolic blood pressure. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: after 5 minut of rest with mercury barometer.	—

Measure

Time frame

FBS. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: 10cc of venous blood was collected before and after the trial and after measuring with special kits.;Triglyceride. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: 10cc of venous blood was collected before and after the trial and after measuring with special kits.;Low density lipoproteien. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: 10cc of venous blood was collected before and after the trial and after measuring with special kits.;Fasting insulin. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: 10cc of venous blood was collected before and after the trial and after measuring with special kits.;Ligh density lipoproteien. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: 10cc of venous blood was collected before and after the trial and after measuring with special kits.;Waist cicumfrance. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: was measured in standing position from the lowest rib to the extremity of the pelvic bone fracture using an anthropometric meter.;Systolic blood pressure. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: after 5 minut of rest with mercury barometer.;Diastolic blood pressure. Timepoint: beginning study befor of using supplement and the end of the study after completion supplement. Method of measurement: after 5 minut of rest with mercury barometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir mansur alavi

Esfahan University of Medical Sciences

am.alavi@nutr.mui.ac.ir+98 31 3668 1378

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026